R. Koster

ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction

R. Collins, M. Keltai, B. Lewis, 1995, The Lancet.

ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION

David Hunt, P Armitage, Sarah Parish, 1992 .

ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction

Raymond C. Schneider, R. Collins, M. Keltai, 1995, The Lancet.

Assessment of the Value of Electrocardiographic Signs for Myocardial Infarction in Left Bundle Branch Block

H. Wellens, G. K. David, K. Lie, 1981 .

Effect of Changes in Liver Blood Flow on the Pharmacokinetics of Saruplase in Patients with Acute Myocardial Infarction

R. Schoemaker, A. Cohen, W. Günzler, 1997, Thrombosis and Haemostasis.

Pharmacokinetics and Pharmacodynamics of Saruplase, an Unglycosylated Single-chain Urokinase-type Plasminogen Activator, in Patients with Acute Myocardial Infarction

A. Cohen, P. A. van der Wouw, R. Koster, 1994, Thrombosis and Haemostasis.

Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity.

C. Boucher, A. Imrie, P. Schipper, 1994, The Journal of infectious diseases.